Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Relation of 91 Circulating Inflammatory Proteins to Nonalcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomisation Study

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 12:49
  • Read more about Relation of 91 Circulating Inflammatory Proteins to Nonalcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomisation Study

Exploring the Genetic Association Between Connective Tissue Diseases and the Risk of Pulmonary Arterial Hypertension: A Mendelian Randomization Analysis

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 12:29
  • Read more about Exploring the Genetic Association Between Connective Tissue Diseases and the Risk of Pulmonary Arterial Hypertension: A Mendelian Randomization Analysis

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 12:21
  • Read more about Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum

Bone morphogenetic proteins, DNA methylation, and gut microbiota interaction in lumbar disc degeneration: A multi-omics Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 12:14
  • Read more about Bone morphogenetic proteins, DNA methylation, and gut microbiota interaction in lumbar disc degeneration: A multi-omics Mendelian randomization study

Chronobiological Patterns and Risk of Acute Aortic Dissection: A Clinical Retrospective and Two-Sample Mendelian Randomisation Study

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 12:05
  • Read more about Chronobiological Patterns and Risk of Acute Aortic Dissection: A Clinical Retrospective and Two-Sample Mendelian Randomisation Study

Identifying prioritization of therapeutic targets for ankylosing spondylitis: a multi-omics Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 11:58
  • Read more about Identifying prioritization of therapeutic targets for ankylosing spondylitis: a multi-omics Mendelian randomization study

Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 11:51
  • Read more about Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer

Genetic correlation and mendelian randomization reveal the impact of sleep traits on urolithiasis risk

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 11:47
  • Read more about Genetic correlation and mendelian randomization reveal the impact of sleep traits on urolithiasis risk

The adverse effect of mood swings on the risk of cardiovascular diseases: Evidence from Mendelian randomization analysis

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 11:16
  • Read more about The adverse effect of mood swings on the risk of cardiovascular diseases: Evidence from Mendelian randomization analysis

Inflammatory proteins and hidradenitis suppurativa: Insights from genetic correlation and Mendelian randomization

Submitted by Frida Mäkelä on Fri, 12/27/2024 - 11:05
  • Read more about Inflammatory proteins and hidradenitis suppurativa: Insights from genetic correlation and Mendelian randomization

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 175
  • Page 176
  • Page 177
  • Page 178
  • Current page 179
  • Page 180
  • Page 181
  • Page 182
  • Page 183
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement